Business
– Teva is battling generic versions of the 20 mg and 40 mg dosages of its MS blockbuster. – In the absence of...
Hi, what are you looking for?
Jewish Business News
Business
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has recalled a batch of its generic Parkinson’s combination drug treatment carbidopa/levodopa because of concern that...
Business
– Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) Israel-based generic drug maker has entered into an agreement with Venus Remedies to sell anti- cancer drug...
Business
– Multiple sclerosis treatment Copaxone accounts for an estimated half of Teva’s profit. – Changes in the multiple sclerosis treatment market, in which...
Business
– The Israeli biomedical company now faces competition for both of its drugs. – The share price of Protalix Biotherapeutics Inc. (NYSE MKT:PLX; TASE:...
Business
– – Gamida Cell’s main investors may sell all their holdings to Novartis at a later stage. – The deal for the sale...
Business
– The generic drug company’s fourth quarter results beat analysts’ estimates. Perrigo Company (NYSE:PRGO; TASE:PRGO) released its fourth quarter and full year results today....
Business
Chiasma: The product is good. This was a strategic decision by Roche to be less involved in hormone-based drugs. – Roche AG (SWX:...
Business
– Israeli biotechnology company Kadimastem (TASE: KDST) has signed a collaboration agreement with Merck to carry out drug screening in the neurodegenerative diseases...
Business
– Sales of the multiple sclerosis treatment were down 12% in the second quarter. – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) reported...